Item
Ashwaganda Extract (7.5% witha (0130)
ASHWAGANDHA EXTRACT from whole plant of Withania somnifera is Intended for Nutraceutical application.
ASHWAGANDHA EXTRACT from whole plant of Withania somnifera is Intended for Nutraceutical application.
Food Ingredient
Attributes
- Gluten-free
- Ingredient declaration
Locations
| Location name | Address |
|---|---|
| SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | 20 LAKE DR 20 lake drive EAST WINDSOR, NJ 08520-5321 |
| Sami-Sabinsa Group Limited, Tumkur District, Kunigal, India | Plot No. 40-41 & 30-35, KIADB Industrial Area, Tumkur District, Kunigal Kunigal, KA 572130 IND |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Allergens | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Allergens.pdf | 5/23/2023 | 5/22/2025 |
| California Prop. 65 | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Ashwagandha Extract Declaration Dec 2019.pdf | 12/27/2019 | 12/26/2021 |
| Gluten | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Ashwagandha Extract Declaration Dec 2019.pdf | 12/27/2019 | 12/26/2020 |
| WADA/NSF/NFL Statement | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Ashwagandha Extract Declaration Dec 2019.pdf | 12/27/2019 | 12/26/2021 |
| Sewage Statement | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Ashwagandha Extract Declaration Dec 2019.pdf | 12/31/2019 | 12/30/2021 |
| No Animal Ingredient Statement | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Ashwagandha Extract Declaration Dec 2019.pdf | 12/30/2019 | 12/29/2020 |
| Safety Data Sheet (SDS) | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Ashwagandha Extract SDS.pdf | 12/30/2019 | 12/29/2022 |
| Shelf Life | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Ashwagandha Extract Spec.pdf | 2/14/2020 | 2/13/2023 |
| Pesticide | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Ashwagandha extract spec.pdf | 12/27/2019 | 12/26/2021 |
| Ingredient Statement | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Ashwagandha extract spec.pdf | 12/27/2019 | 12/26/2020 |
| Heavy Metal | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Ashwagandha extract spec.pdf | 12/27/2019 | 12/26/2021 |
| Residual Statement | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Ashwagandha extract spec.pdf | 12/27/2019 | 12/26/2020 |
| Kosher | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Kosher Ashwagandha Extract.pdf | 12/30/2019 | 6/30/2020 |
| CoA Sample | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | NotApplicable_COASample.pdf | 4/19/2023 | 4/18/2025 |
| Country of Origin | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | NotApplicable_CountryofOrigin.pdf | 4/19/2023 | 4/18/2026 |
| GRAS/NDI/ODI Statement | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | NotApplicable_GRASNDIODIStatement.pdf | 7/26/2023 | 7/25/2026 |
| HACCP Process Flow Diagram | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | NotApplicable_HACCPProcessFlowDiagram.pdf | 4/19/2023 | 4/18/2025 |
| Halal | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | NotApplicable_Halal.pdf | 5/23/2023 | 5/23/2024 |
| Nutrition | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | NotApplicable_Nutrition.pdf | 7/26/2023 | 7/25/2026 |
| EtO Statement | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Sterilization Declaration.pdf | 2/27/2020 | 2/26/2022 |
| Suitability Requirements | SABINSA CORPORATION CORPORATE OFFICE- USA-NJ | Suitability Requirements.pdf | 12/31/2019 | 12/30/2022 |
